A National Survey of Outpatient Parenteral Antibiotic Therapy Practices

Louise E Vaz1, Kimberly K Felder1, Jason G Newland2

  • 1Department of Pediatrics, Oregon Health & Science University, Portland, Oregon, USA.

Insights

Most pediatric infectious diseases (ID) clinicians do not require ID consultation for all outpatient parenteral antibiotic therapy (OPAT) cases. Enhanced ID involvement in post-discharge care is needed for serious infections.

Area of Science:

  • Pediatric Infectious Diseases
  • Antimicrobial Stewardship
  • Healthcare Management

Background:

  • Outpatient parenteral antibiotic therapy (OPAT) is increasingly common for serious pediatric infections.
  • Effective post-discharge follow-up is crucial for optimizing OPAT outcomes and preventing complications.
  • The role of infectious diseases (ID) specialists in managing OPAT and post-discharge care requires further investigation.

Purpose of the Study:

  • To assess current practices of pediatric infectious diseases (ID) clinicians regarding outpatient parenteral antibiotic therapy (OPAT).
  • To evaluate the extent of ID consultation and post-discharge follow-up for pediatric OPAT patients.
  • To identify opportunities for improving ID involvement in the management of serious infections treated with OPAT.

Main Methods:

  • A national survey was distributed to pediatric infectious diseases (ID) clinicians.
  • The survey collected data on OPAT practices, including consultation requirements and post-discharge care protocols.
  • Data analysis focused on current ID involvement and resource allocation for post-discharge care.

Main Results:

  • Only 15% of surveyed sites mandated infectious diseases (ID) consultation for all outpatient parenteral antibiotic therapy (OPAT) cases.
  • Significant variability was observed in the availability of ID division resources dedicated to post-discharge care.
  • Many sites reported limited ID clinician involvement in the ongoing management of patients on OPAT.

Conclusions:

  • Current infectious diseases (ID) consultation rates for pediatric outpatient parenteral antibiotic therapy (OPAT) are suboptimal.
  • There are significant opportunities to enhance the role of ID specialists in the post-discharge management of serious infections.
  • Strengthening ID involvement in OPAT care pathways can improve patient outcomes and antimicrobial stewardship.

Related Concept Videos

Parentral Nutrition: Centeral and Peripheral Parental Nutrition01:27

Parentral Nutrition: Centeral and Peripheral Parental Nutrition

Parenteral Nutrition (PN) delivers essential nutrients directly into the bloodstream, bypassing the digestive system. It is commonly used for individuals with severe digestive disorders or conditions that prevent normal nutrient absorption.
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
346
Routes of Drug Administration: Parenteral01:25

Routes of Drug Administration: Parenteral

The administration of drugs via parenteral routes allows for direct drug introduction into the systemic circulation, resulting in high bioavailability because the medication bypasses the harsh conditions of the gastrointestinal tract and hepatic metabolism.
The intravenous route (IV) of drug administration can be further categorized into two types. The bolus injection administers the entire dose rapidly, while an intravenous infusion slowly delivers smaller doses steadily.
The IV route is often...
2.3K
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
3.1K
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
69
Dosage Regimens: Partial Pharmacokinetic Parameters01:01

Dosage Regimens: Partial Pharmacokinetic Parameters

It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
14
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care01:30

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care

A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
67